Foundation directory
Emerald Foundation Inc Co Solomon Blum Heymann Grants
Private foundation · EIN 13-3912580 · IRS 990-PF filings through tax year 2024
- Total grants paid
- $1.5M
- Grants reported
- 31
- Median grant
- $50K
- Future commitments
- None reported
Giving by tax year
| Tax year | Grants paid | Amount |
|---|---|---|
| 2024 | 31 | $1.5M |
Where Emerald Foundation Inc Co Solomon Blum Heymann gives
States of grant recipients reported on the foundation's 990-PF filings, by dollars received.
Largest reported grants
The biggest individual grants on file, as reported by the foundation to the IRS.
| Recipient | Location | Purpose | Tax year | Amount |
|---|---|---|---|---|
| MASSACHUSETTS INSTITUTE OF TECHNOLO | Cambridge, MA | To study how ferroptosis-based strategies can enhance the efficacy of immunotherapies in breast cancer. | 2024 | $87.5K |
| UNIVERSITY OF MARYLAND SCH OF MEDIC | BALTIMORE, MD | TO INVESTIGATE THE REGULATION OF TREG LYMPHATIC TUMOR MIGRATION AND THE INTERACTION AMONG TREGS, LYMPHATIC ENDOTHELIAL CELLS, AND TUMORS TO DEVELOP STRATEGIES OF DELIVERING TARGETED THERAPIES LOCALLY INSTEAD OF SYSTEMICALLY. | 2024 | $75K |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | CAMBRIDGE, MA | To enhance nanoparticle accumulation in desired cell types to develop more effective and safer targeted nanotherapies. | 2024 | $75K |
| UNIVERSITY OF MARYLAND SCH OF MEDIC | BALTIMORE, MD | To investigate the regulation of Treg lymphatic tumor migration and the interaction among Tregs, lymphatic endothelial cells, and tumors to develop strategies of delivering targeted therapies locally instead of systemically. | 2024 | $75K |
| NYU SCHOOL OF MEDICINE | New York, NY | To examine the cellular mechanisms through which dendrite-centric Alzheimer's disease pathologies result in cognitive dysfunction and hyper-excitability. | 2024 | $75K |
| WEILL CORNELL MEDICINE | New York, NY | To identify regulators of lineage reversion that impact resistance to WNT-targeted therapies in colorectal cancer. | 2024 | $75K |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | To investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer. | 2024 | $50K |
| SALK INSTITUTE FOR BIOLOGICAL STUDI | LA JOLLA, CA | TO USE INNOVATIVE CELL BIOLOGY TECHNIQUES COUPLED WITH GENOMICS TO INVESTIGATE THE ROLE OF MITOCHONDRIAL-DERIVED VESICLES IN CANCER CELL METABOLISM. | 2024 | $50K |
| UNIVERSITY OF KENTUCKY | LEXINGTON, KY | TO UNDERSTAND HOW MALADAPTIVE CHANGES TO THE INTEGRATED STRESS RESPONSE PATHWAY ALTER THE FORCE GENERATING ABILITY OF HUMAN HEART CELLS AND DETERMINE IF PHARMACOLOGICAL MANIPULATION CAN RESCUE CARDIOMYOCYTE FUNCTION. | 2024 | $50K |
| SALK INSTITUTE FOR BIO STUDIES | LA JOLLA, CA | To use innovative cell biology techniques coupled with genomics to investigate the role of mitochondrial-derived vesicles in cancer cell metabolism. | 2024 | $50K |
| WHITEHEAD INST FOR BIOMEDICAL RESEA | CAMBRIDGE, MA | To identify molecular mechanisms that help anaerobes cope with oxygen exposure and/or oxidative stress. | 2024 | $50K |
| WHITEHEAD INST FOR BIOMEDICAL RESEA | CAMBRIDGE, MA | To identify molecular mechanisms that help anaerobes cope with oxygen exposure and/or oxidative stress. | 2024 | $50K |
| INSERM DR GRAND OUEST | NANTES, Cedex 1 | To determine the mechanism through which breast cancer cell clusters dissociate into single cells and proliferate at distant sites and to determine the impact of the new environment on metastasis formation. | 2024 | $50K |
| UNIVERSITY OF PENNSYLVANIA | Philadelphia, PA | To understand the molecular mechanism underlying immunosuppression and immunoactivation and develop new treatment strategies for hepatic malignancies. | 2024 | $50K |
| DANA-FARBER CANCER INSTITUTE | BOSTON, MA | To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches. | 2024 | $50K |
| UNIVERSITY OF MICHIGAN | Ann Arbor, MI | To use tumor organoid and mouse models to determine how loss of Claudin proteins impacts tumor invasion and metastasis. | 2024 | $50K |
| DANA-FARBER CANCER INSTITUTE | Boston, MA | To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches. | 2024 | $50K |
| WHITEHEAD INST FOR BIOMEDICAL RESEA | CAMBRIDGE, MA | To uncover the set of cell-surface proteins that mediate essential interactions between PDAC cells and their microenvironment. | 2024 | $50K |
| UNIVERSITY OF PENNSYLVANIA | Philadelphia, PA | To understand the molecular mechanism underlying immunosuppression and immunoactivation and develop new treatment strategies for hepatic malignancies. | 2024 | $50K |
| UNIVERSITY OF KENTUCKY | Lexington, KY | To understand how maladaptive changes to the integrated stress response pathway alter the force generating ability of human heart cells and determine if pharmacological manipulation can rescue cardiomyocyte function. | 2024 | $50K |
| WEILL CORNELL MEDICINE | New York, NY | To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence. | 2024 | $37.5K |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | To use tumor organoid and mouse models to determine how loss of claudin proteins impacts tumor invasion and metastasis. | 2024 | $37.5K |
| WEILL CORNELL MEDICINE | NEW YORK, NY | To characterize exosomes from nave and tumor-educated platelets and determine their contribution to metastatic dormancy and recurrence. | 2024 | $37.5K |
| FOX CHASE CANCER CENTER | PHILADELPHIA, PA | To investigate the role of Brg1-dependent epigenetic regulation on PDAC fibroblast pro-tumorigenic functions. | 2024 | $37.5K |
| CALIFORNIA INSITUTE OF TECHNOLOGY | PASADENA, CA | To develop interpretable machine learning methods that link spatial phenotypes in imaging data of solid tumors with patient outcomes. | 2024 | $37.5K |
How to apply
This foundation reports on its 990-PF that it only makes contributions to preselected organizations and does not accept unsolicited applications.
About this data
Figures are aggregated from Emerald Foundation Inc Co Solomon Blum Heymann's IRS Form 990-PF electronic filings (1 filing on file, most recent tax year 2024). Totals reflect grants the foundation reported as paid, and can lag the current year because foundations file annually and often on extension. Source: IRS 990-PF e-file archive.